Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors
Authors:
- Patricia J. McLaughlinPMPatricia J. McLaughlin
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 480 (1-2) , 16-28
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systemsLife Sciences, 1987
- A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addictsLife Sciences, 1986
- Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells.Journal of Cell Biology, 1986
- Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: A role for endogenous opioid systems in cancerLife Sciences, 1984
- Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: Biochemical and behavioral correlatesLife Sciences, 1984
- Enkephalins as immunomodulatorsInternational Journal of Immunopharmacology, 1983
- Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatmentLife Sciences, 1982
- Differential effects of chronic morphine and naloxone on opiate receptors, monoamines, and morphine-induced behaviors in preweanling ratsDevelopmental Brain Research, 1982
- Naloxone prolongs the survival time of mice treated with neuroblastomaLife Sciences, 1981
- β-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiatesLife Sciences, 1978